To overview		Product Launch at AAO

	Carl Zeiss Meditec Launches Unique Optical Coherence Tomography System for the Anterior Segment		Downloads and Links
	Visante™ OCT is a versatile, non-contact system for anterior segment imaging and biometry		RTF Documents english (505 KB) Further Information Visante™ OCT ZEISS AAO Portal Carl Zeiss Meditec
	CHICAGO/Illinois/USA, 06.10.2005. Carl Zeiss Meditec, Inc., a leader in ophthalmic devices and systems, today announced that the U.S. Food and Drug Administration has granted 510(k) clearance for Visante™ OCT. The device is the first stand-alone, high-resolution optical coherence tomography (OCT) imaging system for the anterior segment of the eye, including the cornea, iris, angle and the lens. Visante OCT is being showcased at the American Academy of Ophthalmology Annual Meeting in Chicago (Booth #3534), October 15-18. “Our Stratus™ OCT is the emerging gold standard for obtaining high-resolution cross-sectional images of the retina,” said Jim Taylor, Carl Zeiss Meditec president and chief executive officer. “Now with Visante OCT, this technology is customized for anterior segment applications.” Without the need for ocular anesthesia or water bath, Visante OCT can accurately measure corneal thickness to help qualify patients for vision correction surgery. In addition to providing a full-thickness pachymetry map prior to laser surgery, it is the first device to image, measure and document both corneal flap thickness and residual stromal thickness immediately following the procedure – a crucial element in ensuring optimal surgical outcomes. “Visante OCT provides me with the clinical confidence I demand for precise evaluation of the anterior segment,” said Dr. John A. Vukich, an ophthalmologist at Davis Duehr Dean in Madison, Wis. “This technology adds a new level of accuracy and safety for patients who are considering or have already undergone LASIK surgery.” The Visante OCT software allows for precise evaluation, measurement and analysis of the anterior segment. Practical tools enable detailed planning and measurement of anterior segment structures, including anterior chamber depth (ACD), anterior chamber angles and the angle-to-angle distance (anterior chamber diameter). Visante OCT also aids postoperative evaluation by allowing imaging and measurement of intraocular lenses (IOLs) and implants in the eye. As part of the company’s comprehensive education program, Carl Zeiss Meditec will offer the following presentations in their booth theater during the upcoming AAO annual meeting: Value of the Anterior Segment OCT for Phakic IOL Implantation, Saturday, October 15, 4 p.m., Camille Budo, M.D., Sint Truiden, Belgium First Clinical Results with the Anterior Segment OCT: Evaluation of patients for refractive surgery, Saturday, October 15, 4:30 p.m. and Sunday, October 16, 4 p.m., Professor Thomas Kohnen, M.D., Frankfurt, Germany Evaluation of the Anterior Segment with the Visante OCT, Saturday, October 15, 5:30 p.m. and Sunday, October 16, 4:30 p.m., Ike Ahmed, MD, Toronto, Canada Visante OCT Applications for the Anterior Segment Surgeons, Sunday, October 16, 9:30 a.m., Mark Packer, M.D., Eugene, Ore. Refractive surgery applications of Visante Anterior Segment OCT, Sunday, October 16, 10 a.m. and Monday, October 17, 12:30 p.m., John A. Vukich, M.D., Madison Wis. Anterior Segment OCT: Overview and Clinical Correlations, Monday, October 17, noon, Richard Hoffman, M.D., Eugene, Ore. Pre-op and Post-op Examination of Verisyse Lens Patients Using the Anterior Segment OCT, Monday, October 17, 4:30 p.m., Josep LI. Güell, M.D., Barcelona, Spain Using the Visante OCT for Studying the Anterior Segment, Tuesday, October 18, 10 a.m., Professor Georges Baikoff, M.D., Marseille, France For additional information about Visante OCT and all Carl Zeiss Meditec products, contact Customer Service at +1 800-342-9821 or visit the ZEISS AAO portal at http://www.zeiss.com/aao. Jackie Ferreira Carl Zeiss Meditec, Inc. Marketing Manager Phone: +1 925-557-4488 Fax: +1-925-557-4675 E-Mail: j.ferreira@meditec.zeiss.com Rebecca Macdonald FischerHealth +1 310-577-7870 ext. 116 E-Mail: rmacdonald@fischerhealth.com Number: M13/05 OP Number of Words: 560 Number of Characters: 4034

Go To Top To overview